Timothy S. Nelson, President and CEO at MAP Pharmaceuticals, Inc. (MAPP), sold 20,000 shares at $12.17 ($243K) on 2010-01-11, disclosed to the SEC on 2010-01-13.
Scheduled sale ($243k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MAPP | SELL | 2011-12-22 | $290K | — | Filing → |
| MAPP | SELL | 2010-07-02 | $182K | — | Filing → |
| MAPP | SELL | 2010-06-03 | $432K | — | Filing → |